Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a TMA Assay for the Screening of HIV-1 RNA, HCV RNA and HBV DNA in Human Blood Donor Plasma Specimens

NCT00552214 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00552214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00552214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a TMA Assay for the Screening of HIV-1 RNA, HCV RNA and HBV DNA in Human Blood Donor Plasma Specimens
Lead sponsor
Novartis
Phase
Not applicable
Overall status
Completed
Start date
August 8, 2007
Completion date
July 1, 2008
Enrollment
10,290 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

screening for the presence of hiv-1, rna and hbv dna in blood donations